Researchers at Rush are leading efforts to cure disease and promote health equity — in Chicago and around the world. Our students and faculty work together on the frontiers of clinical, basic science and community-based research, in order to improve care for patients at Rush and beyond.
Nearly 40% of older adults may experience brain damage caused by Limbic-predominant Age-related TDP-43 Encephalopathy (LATE), a form of dementia often mistaken for Alzheimer’s disease, according to an NIA-supported study led by researchers at Rush Medical College and the University of Kentucky.
More than half of patients with hypertension do not take their medication as prescribed. A team of Rush researchers led by Todd Ruppar, PhD, RN, FAHA, FAAN, is testing telehealth strategies to help them stay on track. Read more
Associate professor and neuropathologist Julie Schneider, MD, MS, authored a new study which suggests a bioactive compound in strawberries may be associated with fewer neurofibrillary tau tangles in the brain—one of the hallmarks of Alzheimer’s disease. Read more
Pulse oximeters became a critical diagnostic tool during the COVID-19 pandemic. But new research indicates that the oximeter is less accurate for patients with darker skin tones, and may cause treatment to be delayed or missed in patients of color. Read more
